多重自身免疫性:神经炎光学谱系障碍与兰伯特-伊顿肌肌综合征
Isobel Sarah Platt1,2, Albert Joseph2, Vasiliki Tsirka3
1Department of Clinical and Movement Neurosciences, University College London, London, UK.
Practical neurology
|February 18, 2025
概括
这一案例突出了一个患有神经omyelitis optica光谱障碍 (NMOSD) 的患者,他发展了兰伯特-伊顿肌肌综合征 (LEMS). 识别LEMS对于管理神经肌肉症状的NMOSD患者至关重要.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 一名56岁的妇女患有水素-4抗体阳性神经脊髓炎光学谱障碍 (AQ4-NMOSD),呈现出逐渐下降的运动能力,体重减轻和声.
- 她的病史包括自身免疫性甲状腺毒毒症和高血压,显著的吸烟史引起了对恶性瘤的初步担忧.
研究的目的:
- 描述一例罕见的同时发生的兰伯特-伊顿肌综合征 (LEMS) 病例,该病例发生在患者中,该患者已被诊断为AQ4-NMOSD.
- 强调在已确诊的NMOSD患者中考虑和诊断其他自身免疫性疾病的重要性.
主要方法:
- 临床表现和神经生理学检查是关键的诊断工具.
- 电生理学揭示了前突触神经肌肉结位功能障碍.
- 抗体检测证实了高压通道抗体的升高,导致LEMS诊断.
主要成果:
- 该患者被诊断出患有兰伯特-伊顿骨髓综合征 (LEMS),同时她现有的AQ4-NMOSD.
- 在LEMS管理方面,开始使用3,4-diaminopyridine和rituximab治疗.
- 连续的FDG-PETCT扫描还没有确定潜在的恶性瘤.
结论:
- 兰伯特-伊顿肌综合征 (LEMS) 可以在患有神经髓炎光学谱系障碍 (NMOSD) 的患者中出现.
- 大约一半的LEMS病例与其他自身免疫性疾病有关.
- 及时识别和治疗LEMS等同时发生的自身免疫性疾病对于NMOSD患者的结果至关重要.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
601
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
601
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K


